Fibrinogen Gamma (FGg)
Fibrinogen gamma chain is the gamma component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots.
In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Mutations in this gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia and thrombophilia. Alternative splicing results in two transcript variants encoding different isoforms.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPC477Hu01 Recombinant Fibrinogen Gamma (FGg) Positive Control; Immunogen; SDS-PAGE; WB.
EPC477Hu51 Eukaryotic Fibrinogen Gamma (FGg) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAC477Hu01 Polyclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC; IP.
MAC477Hu22 Monoclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC; IP.
LAC477Hu71 Biotin-Linked Polyclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC.
LAC477Hu81 FITC-Linked Polyclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC; IF.
PAC477Hu07 Polyclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC; IP.
MAC477Hu21 Monoclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC; IP.
Assay Kits SEC477Hu ELISA Kit for Fibrinogen Gamma (FGg) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPC477Mu01 Recombinant Fibrinogen Gamma (FGg) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAC477Mu01 Polyclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC; IP.
LAC477Mu71 Biotin-Linked Polyclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC.
Assay Kits SEC477Mu ELISA Kit for Fibrinogen Gamma (FGg) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPC477Ra01 Recombinant Fibrinogen Gamma (FGg) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAC477Ra01 Polyclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC; IP.
LAC477Ra71 Biotin-Linked Polyclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC.
LAC477Ra81 FITC-Linked Polyclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC; IF.
MAC477Ra21 Monoclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC; IP.
Assay Kits SEC477Ra ELISA Kit for Fibrinogen Gamma (FGg) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Bos taurus; Bovine (Cattle)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPC477Bo01 Recombinant Fibrinogen Gamma (FGg) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAC477Bo01 Polyclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC; IP.
Assay Kits n/a CLIA Kit for Fibrinogen Gamma (FGg) CLIA Kit Customized Service Offer
n/a ELISA Kit for Fibrinogen Gamma (FGg) ELISA Kit Customized Service Offer

Organism species: Chicken (Gallus)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPC477Ga01 Recombinant Fibrinogen Gamma (FGg) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAC477Ga01 Polyclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC; IP.
LAC477Ga71 Biotin-Linked Polyclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC.
LAC477Ga81 FITC-Linked Polyclonal Antibody to Fibrinogen Gamma (FGg) WB; IHC; ICC; IF.
Assay Kits n/a CLIA Kit for Fibrinogen Gamma (FGg) CLIA Kit Customized Service Offer
n/a ELISA Kit for Fibrinogen Gamma (FGg) ELISA Kit Customized Service Offer
  1. "Characterization of a complementary deoxyribonucleic acid coding for the gamma chain of human fibrinogen."Biochemistry 22:3250-3256(1983) [PubMed] [Europe PMC] [Abstract]
  2. "Nucleotide sequence of the gene for the gamma chain of human fibrinogen."Biochemistry 24:2077-2086(1985) [PubMed] [Europe PMC] [Abstract]
  3. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Human fibrinogen: sequence, sulfur bridges, glycosylation and some structural variants."(In) Peeters H. (eds.);Protides of the biological fluids, Proc. 28th colloquium, pp.51-56, Pergamon Press, Oxford (1980)
  6. "Evidence for the selective association of a subpopulation of GPIIb-IIIa with the actin cytoskeletons of thrombin-activated platelets."J. Cell Biol. 121:1329-1342(1993) [PubMed] [Europe PMC] [Abstract]
  7. "Polymorphism of the human gamma chain fibrinogen gene."DNA Seq. 1:419-422(1991) [PubMed] [Europe PMC] [Abstract]
  8. "Isolation and characterisation of cDNA clones for the A alpha- and gamma-chains of human fibrinogen."Nucleic Acids Res. 11:7427-7434(1983) [PubMed] [Europe PMC] [Abstract]
  9. "Structure of the human gamma-fibrinogen gene. Alternate mRNA splicing near the 3' end of the gene produces gamma A and gamma B forms of gamma-fibrinogen."J. Biol. Chem. 259:12826-12830(1984) [PubMed] [Europe PMC] [Abstract]
  10. "Abnormal polymerization and normal binding of plasminogen and t-PA in three new dysfibrinogenaemias: Barcelona III and IV (gamma Arg 275-->His) and Villajoyosa (gamma Arg 275-->Cys)."Blood Coagul. Fibrinolysis 6:198-206(1995) [PubMed] [Europe PMC] [Abstract]
  11. "Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma')."Biochemistry 20:6146-6149(1981) [PubMed] [Europe PMC] [Abstract]
  12. "Covalent structure of fibrinogen."Ann. N. Y. Acad. Sci. 408:28-43(1983) [PubMed] [Europe PMC] [Abstract]
  13. "The structures of fibrinogen and fibrin."(In) Magnusson S., Ottesen M., Foltmann B., Dano K., Neurath H. (eds.);Regulatory proteolytic enzymes and their inhibitors, pp.163-172, Pergamon Press, New York (1978)
  14. "Disulfide bridges in NH2-terminal part of human fibrinogen."Thromb. Res. 8:639-658(1976) [PubMed] [Europe PMC] [Abstract]
  15. "Dimeric half-molecules of human fibrinogen are joined through disulfide bonds in an antiparallel orientation."Biochemistry 22:2049-2055(1983) [PubMed] [Europe PMC] [Abstract]
  16. "Recombinant human fibrinogen and sulfation of the gamma' chain."Biochemistry 30:9414-9420(1991) [PubMed] [Europe PMC] [Abstract]
  17. "The amino acid sequence in fibrin responsible for high affinity thrombin binding."Thromb. Haemost. 85:470-474(2001) [PubMed] [Europe PMC] [Abstract]
  18. "Fibrinogen and fibrin."Annu. Rev. Biochem. 53:195-229(1984) [PubMed] [Europe PMC] [Abstract]
  19. "Localization of a fibrin gamma-chain polymerization site within segment Thr-374 to Glu-396 of human fibrinogen."Proc. Natl. Acad. Sci. U.S.A. 81:5980-5984(1984) [PubMed] [Europe PMC] [Abstract]
  20. "Localization of a fibrin polymerization site."J. Biol. Chem. 256:3544-3549(1981) [PubMed] [Europe PMC] [Abstract]
  21. "Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain."Biochemistry 23:1767-1774(1984) [PubMed] [Europe PMC] [Abstract]
  22. "Evidence that three adhesive proteins interact with a common recognition site on activated platelets."J. Biol. Chem. 259:5388-5391(1984) [PubMed] [Europe PMC] [Abstract]
  23. "Localization of a fibrinogen calcium binding site between gamma-subunit positions 311 and 336 by terbium fluorescence."J. Biol. Chem. 260:9713-9719(1985) [PubMed] [Europe PMC] [Abstract]
  24. "Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma')."Proc. Natl. Acad. Sci. U.S.A. 77:5069-5073(1980) [PubMed] [Europe PMC] [Abstract]
  25. "Screening for N-glycosylated proteins by liquid chromatography mass spectrometry."Proteomics 4:454-465(2004) [PubMed] [Europe PMC] [Abstract]
  26. "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry."J. Proteome Res. 4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract]
  27. "Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach."Mol. Cell. Proteomics 5:226-233(2006) [PubMed] [Europe PMC] [Abstract]
  28. "Identification of N-linked glycoproteins in human milk by hydrophilic interaction liquid chromatography and mass spectrometry."Proteomics 8:3833-3847(2008) [PubMed] [Europe PMC] [Abstract]
  29. "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
  30. "A strategy for precise and large scale identification of core fucosylated glycoproteins."Mol. Cell. Proteomics 8:913-923(2009) [PubMed] [Europe PMC] [Abstract]
  31. "A unique proteolytic fragment of human fibrinogen containing the A alpha COOH-terminal domain of the native molecule."J. Biol. Chem. 265:13669-13676(1990) [PubMed] [Europe PMC] [Abstract]
  32. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  33. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  34. "Crystal structure of a 30 kDa C-terminal fragment from the gamma chain of human fibrinogen."Structure 5:125-138(1997) [PubMed] [Europe PMC] [Abstract]
  35. "The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro."Proc. Natl. Acad. Sci. U.S.A. 94:7176-7181(1997) [PubMed] [Europe PMC] [Abstract]
  36. "Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin."Nature 389:455-462(1997) [PubMed] [Europe PMC] [Abstract]
  37. "Crystal structure of fragment double-D from human fibrin with two different bound ligands."Biochemistry 37:8637-8642(1998) [PubMed] [Europe PMC] [Abstract]
  38. "Conformational changes in fragments D and double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide."Biochemistry 38:2941-2946(1999) [PubMed] [Europe PMC] [Abstract]
  39. "A gamma methionine-310 to threonine substitution and consequent N-glycosylation at gamma asparagine-308 identified in a congenital dysfibrinogenemia associated with posttraumatic bleeding, fibrinogen Asahi."J. Clin. Invest. 83:1590-1597(1989) [PubMed] [Europe PMC] [Abstract]
  40. "Gene analyses of abnormal fibrinogens with a mutation in the gamma chain."Int. J. Hematol. 56:129-134(1992) [PubMed] [Europe PMC] [Abstract]
  41. "Fibrinogen Baltimore I: polymerization defect associated with a gamma 292Gly-->Val (GGC-->GTC) mutation."Blood 76:2279-2283(1990) [PubMed] [Europe PMC] [Abstract]
  42. "Polymerization defect of fibrinogen Baltimore III due to a gamma Asn308-->Ile mutation."Blood 75:1659-1663(1990) [PubMed] [Europe PMC] [Abstract]
  43. "Fibrinogen Bern I: substitution gamma 337 Asn-->Lys is responsible for defective fibrin monomer polymerization."Blood 82:2104-2108(1993) [PubMed] [Europe PMC] [Abstract]
  44. "Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site."J. Biol. Chem. 263:13848-13856(1988) [PubMed] [Europe PMC] [Abstract]
  45. "Fibrinogen Kyoto III: a congenital dysfibrinogen with a gamma aspartic acid-330 to tyrosine substitution manifesting impaired fibrin monomer polymerization."Blood 74:2681-2687(1989) [PubMed] [Europe PMC] [Abstract]
  46. "Characterization of fibrinogen Milano I: amino acid exchange gamma 330 Asp-->Val impairs fibrin polymerization."Blood 67:1751-1756(1986) [PubMed] [Europe PMC] [Abstract]
  47. "Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution."Blood Coagul. Fibrinolysis 5:463-471(1994) [PubMed] [Europe PMC] [Abstract]
  48. "A new substitution, gamma 358 Ser-->Cys, in fibrinogen Milano VII causes defective fibrin polymerization."Blood 84:1874-1880(1994) [PubMed] [Europe PMC] [Abstract]
  49. "Fibrinogen Nagoya, a replacement of glutamine-329 by arginine in the gamma-chain that impairs the polymerization of fibrin monomer."J. Biochem. 105:10-14(1989) [PubMed] [Europe PMC] [Abstract]
  50. "Substitution of gamma Arg-275 by Cys in an abnormal fibrinogen, 'fibrinogen Osaka II'. Evidence for a unique solitary cystine structure at the mutation site."J. Biol. Chem. 263:13579-13587(1988) [PubMed] [Europe PMC] [Abstract]
  51. "Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant."Thromb. Haemost. 68:534-538(1992) [PubMed] [Europe PMC] [Abstract]
  52. "Characterization of an abnormal fibrinogen Osaka V with the replacement of gamma-arginine 375 by glycine. The lack of high affinity calcium binding to D-domains and the lack of protective effect of calcium on fibrinolysis."J. Biol. Chem. 267:2753-2759(1992) [PubMed] [Europe PMC] [Abstract]
  53. "Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain."Thromb. Haemost. 69:217-220(1993) [PubMed] [Europe PMC] [Abstract]
  54. "An apparently higher molecular weight gamma-chain variant in a new congenital abnormal fibrinogen Tochigi characterized by the replacement of gamma arginine-275 by cysteine."Blood 71:480-487(1988) [PubMed] [Europe PMC] [Abstract]
  55. "A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization."J. Biol. Chem. 266:13456-13461(1991) [PubMed] [Europe PMC] [Abstract]
  56. "Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg-->His): fibrinogens Bergamo II, Essen and Perugia."Thromb. Haemost. 56:401-406(1986) [PubMed] [Europe PMC] [Abstract]
  57. "Normal plasmic cleavage of the gamma-chain variant of 'fibrinogen Saga' with an Arg-275 to His substitution."Thromb. Haemost. 60:476-480(1988) [PubMed] [Europe PMC] [Abstract]
  58. "Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, A-alpha R16C and gamma G165R."Blood 98:351-357(2001) [PubMed] [Europe PMC] [Abstract]
  59. "Characterization of single-nucleotide polymorphisms in coding regions of human genes."Nat. Genet. 22:231-238(1999) [PubMed] [Europe PMC] [Abstract]
  60. ErratumNat. Genet. 23:373-373(1999)
  61. "Fibrinogen Hillsborough: a novel gamma-gly309asp dysfibrinogen with impaired clotting."Blood 99:3597-3601(2002) [PubMed] [Europe PMC] [Abstract]
  62. "Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to gamma S378P mutation."Blood 105:3162-3168(2005) [PubMed] [Europe PMC] [Abstract]
  63. "Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency."Thromb. Haemost. 113:567-576(2015) [PubMed] [Europe PMC] [Abstract]